Search results
FDA tells Covid-19 vaccine makers to update shot to target current virus variant
WKBT La Crosse· 6 days agoThe FDA’s committee of independent advisers voted unanimously Wednesday to recommend that the agency...
FDA vaccine advisers vote unanimously in favor of updated COVID-19 shot for fall
WYFF 4 Greenville· 7 days agoThe Food and Drug Administration’s committee of independent advisers voted unanimously Wednesday to...
There's another COVID variant you should know about: KP.3 now makes up 25% of COVID cases
USA Today· 5 days agoThe Centers for Disease Control and Prevention data shows that a new COVID variant, the KP.3 variant...
'FLiRT' variants account for 65% of COVID-19 cases: CDC
Becker’s Hospital Review· 3 days agoThe FLiRT variants refer to a group of variants — including all that start with the letters "KP" or "JN" — that have independently acquired the same set ...
Health officials keep eye on ‘FLiRT’ COVID variants that could lead to fall surge
Cumberland Times-News· 2 days agoWith Maryland nearing 1.5 million reported cases of COVID-19 since the start of the pandemic,...
APH ends COVID-19 case reporting; monitoring and pandemic prep continues
Community Impact· 1 day agoMore than four years after the COVID-19 pandemic began, Austin Public Health ended its close...
A Combined Flu and COVID-19 Shot May Be Coming
Time via AOL· 3 days agoThe specific strains targeted in the shot will depend on which forms of the viruses are circulating at the time. (The company also filed a request to the...
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
Benzinga via AOL· 6 days ago(NASDAQ:MRNA) announced that it has submitted an FDA application for review of its Spikevax...
The FDA tells Covid-19 vaccine makers to update shot to target the variant currently in circulation
News Channel Nebraska· 6 days agoOnly 3% to 4% of people who are getting tested are positive for the virus, the CDC told the FDA’s...
FDA Advises Covid-19 Vaccine Makers to Tackle JN.1 Variant
Morningstar· 6 days agoBy Sabela Ojea The Food and Drug Administration has recommended that manufacturers of Covid-19 vaccines should focus on the JN.1 variant